|
Hear comprehensive coverage on:
-
DEVELOPING microRNA TOOLS INTO
TISSUE-SPECIFIC DIAGNOSTIC MARKERS
-
microRNA DYSFUNCTION REGULATION
-
PATHWAY ANALYSIS FEATURES TO MODEL
ORGANISM DATABASES
-
TOXICITY PATHWAYS
-
REAL IMPACT OF PATHWAY TOOLS
-
PATHWAY APPROACH TO UNDERSTANDING
OFF-TARGET EFFECTS
HIGHLIGHTED PRESENTATIONS:
 George A. Calin, M.D., Ph.D.
Associate Professor, Department of Experimental Therapeutics University of Texas, MD Anderson Cancer Centre
 Andrea
Califano, Ph.D. Professor and Director, Genome Center Bioinformatics
Columbia University
 Pablo
Landgraf, M.D., Ph.D. Group Leader, Department of Pediatric
Oncology, Hematology and Clinical Immunology Children's Hospital of the Heinrich-Heine University D丒seldorf
 Isidore Rigoutsos, Ph.D. Manager, Bioinformatics & Pattern
Discovery Group, Computational Biology Center IBM Thomas J. Watson Research Center
 Peter Karp, Ph.D.
Director, Bioinformatics Research
Group, SRI International
 Rex Chisholm, Ph.D.
Director, Genetic Medicine, RH Lurie Cancer Center Northwestern University
 Jeff Kiefer, Ph.D.
Head of Knowledge Mining and
Bioinformatics, Pharmaceutical Genomics Division
TGEN
 Arthur L. Holden
Chairman and CEO International SAE Consortium, Ltd.
 Phil Hewitt, Ph.D.
UK and Eurotox Registered
Toxicologist, Head of Toxicogenomics, Non Clinical Development
Toxicology Darmstadt Merck Serono Research
 John K.
Westwick, Ph.D. President and Chief Executive Officer Odyssey Thera, Inc.
|
Japanese
Korean
English